Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Issues related to Medicaid and CHIP as it relates to rare pediatric diseases. H.R. 1628, The American Health Care Act of 2017 and issues related to Medicaid and high risk populations. Issues related to novel therapies for rare pediatric populations; H.R. 1628, The American Health Care Act of 2017; issues related to Medicaid and high risk populations; monitored issues related to S.204, the Trickett Wendler Right to Try Act of 2017; monitored issues related to the consideration of S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
EMILY PORTER STACEY HUGHES KATHERINE RAAB (House Cmte on Energy and Commerce, Prof. Staff; Congressman Mary Bono, Leg. Asst.; Congressman Elton Gallegly, Leg. Asst.; Congressman Michael Bilirakis, Leg. Asst.; Congressman Michael Bilirakis, Leg. Corr.; Congressman Michael Bilirakis, Staff Asst) STACEY HUGHES EMILY PORTER KATHERINE RAAB (House Cmte on Energy and Commerce, Prof. Staff; Congressman Mary Bono, Leg. Asst.; Congressman Elton Gallegly, Leg. Asst.; Congressman Michael Bilirakis, Leg. Asst.; Congressman Michael Bilirakis, Leg. Corr.; Congressman Michael Bilirakis, Staff Asst)
House Cmte on Energy and Commerce, Prof. Staff; Congressman Mary Bono, Leg. Asst.; Congressman Elton Gallegly, Leg. Asst.; Congressman Michael Bilirakis, Leg. Asst.; Congressman Michael Bilirakis, Leg. Corr.; Congressman Michael Bilirakis, Staff Asst House Cmte on Energy and Commerce, Prof. Staff; Congressman Mary Bono, Leg. Asst.; Congressman Elton Gallegly, Leg. Asst.; Congressman Michael Bilirakis, Leg. Asst.; Congressman Michael Bilirakis, Leg. Corr.; Congressman Michael Bilirakis, Staff Asst